Clinical trial

Exploring a Breast Cancer Early Screening Model Based on cfDNA

NCT06016790

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2023-04-11

PhaseN/A

Study timeline

Study start (actual)2023-04-11Date precision: day

Registry last updated2025-07-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Breast Fibroadenomaunresolved

Breast Hypoplasiaunresolved

Interventions

cfDNA sequencingGENETIC

Sponsors & collaborators

Second Affiliated Hospital, Zhejiang University, School of Medicinelead sponsor

OmixScience Institutecollaborator

Mapped research locations

HangzhouZhejiang, China6

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06016790 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.